Table 3. Microbiological Characteristics.
Variable | Enterobacter cloacae-associated PJI (n = 12) | |
---|---|---|
Microbial culture | ||
Monomicrobial | 4 (33.3) | |
Polymicrobial | 8 (66.7) | |
Associated bacteria | ||
Staphylococcus species | 5 (41.7) | |
Pseudomonas aeruginosa | 4 (33.3) | |
Enterococcus faecalis | 2 (16.7) | |
Klebsiella pneumoniae | 2 (16.7) | |
Other gram-negative bacteria | 2 (16.7) | |
E. cloacae drug resistance | ||
Trimethoprim/sulfamethoxazole | 6 (50.0) | |
Ceftriaxone | 5 (41.7) | |
Gentamicin | 5 (41.7) | |
Ceftazidime | 4 (33.3) | |
Chloramphenicol | 4 (33.3) | |
Cefuroxime | 3 (25.0) | |
Amoxicillin | 2 (16.7) | |
Piperacillin/tazobactam | 2 (16.7) | |
Cefazolin | 1 (8.3) | |
Ciprofloxacin | 1 (8.3) | |
Ertapenem | 1 (8.3) | |
Imipenem | 1 (8.3) | |
Meropenem | 1 (8.3) | |
Tobramycin | 1 (8.3) |
Values are presented as number (%).
PJI: periprosthetic joint infection.